CT45A3
gene geneOn this page
Also known as CT45-3CT45.3CT45-4CT45.4
Summary
CT45A3 (cancer/testis antigen family 45 member A3, HGNC:33268) is a protein-coding gene on chromosome Xq26.3, encoding Cancer/testis antigen family 45 member A3 (Q8NHU0).
Located in nucleus.
Source: NCBI Gene 441519 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 11 total
- MANE Select transcript:
NM_001370148
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33268 |
| Approved symbol | CT45A3 |
| Name | cancer/testis antigen family 45 member A3 |
| Location | Xq26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CT45-3, CT45.3, CT45-4, CT45.4 |
| Ensembl gene | ENSG00000269096 |
| Ensembl biotype | protein_coding |
| OMIM | 300794 |
| Entrez | 441519 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000597510, ENST00000598716
RefSeq mRNA: 3 — MANE Select: NM_001370148
NM_001017435, NM_001370148, NM_001370149
CCDS: CCDS76030
Canonical transcript exons
ENST00000598716 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001830036 | 135768108 | 135768191 |
| ENSE00003017646 | 135761634 | 135761727 |
| ENSE00003038936 | 135762108 | 135762356 |
| ENSE00003193431 | 135760044 | 135760409 |
| ENSE00003718024 | 135764276 | 135764450 |
Expression profiles
Bgee: expression breadth broad, 41 present calls, max score 90.16.
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.16 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.06 | gold quality |
| right testis | UBERON:0004534 | 78.45 | gold quality |
| testis | UBERON:0000473 | 75.34 | gold quality |
| left testis | UBERON:0004533 | 73.87 | gold quality |
| Ammon’s horn | UBERON:0001954 | 50.71 | gold quality |
| prefrontal cortex | UBERON:0000451 | 48.91 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 48.11 | gold quality |
| nucleus accumbens | UBERON:0001882 | 47.43 | gold quality |
| hypothalamus | UBERON:0001898 | 47.17 | gold quality |
| caudate nucleus | UBERON:0001873 | 46.23 | gold quality |
| putamen | UBERON:0001874 | 43.51 | gold quality |
| substantia nigra | UBERON:0002038 | 43.48 | gold quality |
| amygdala | UBERON:0001876 | 43.40 | gold quality |
| temporal lobe | UBERON:0001871 | 43.21 | gold quality |
| sural nerve | UBERON:0015488 | 42.50 | gold quality |
| frontal cortex | UBERON:0001870 | 42.09 | gold quality |
| cerebral cortex | UBERON:0000956 | 40.82 | gold quality |
| brain | UBERON:0000955 | 39.94 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 38.17 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 37.84 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| adenohypophysis | UBERON:0002196 | 35.81 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 35.69 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 35.08 | gold quality |
| primary visual cortex | UBERON:0002436 | 33.82 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.48 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting CT45A3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-5572 | 98.55 | 65.84 | 970 |
| HSA-MIR-6819-5P | 97.96 | 66.59 | 1071 |
| HSA-MIR-3151-3P | 97.80 | 66.16 | 479 |
| HSA-MIR-6737-5P | 97.75 | 66.54 | 1044 |
| HSA-MIR-6812-5P | 97.56 | 65.39 | 1059 |
| HSA-MIR-3674 | 97.01 | 68.86 | 1171 |
| HSA-MIR-6747-5P | 96.17 | 64.99 | 743 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ct45a | ENSMUSG00000064016 |
| rattus_norvegicus | Ct45a9 | ENSRNOG00000048059 |
| drosophila_melanogaster | IntS6 | FBGN0261383 |
| caenorhabditis_elegans | WBGENE00000994 |
Paralogs (11): INTS6 (ENSG00000102786), INTS6L (ENSG00000165359), SAGE1 (ENSG00000181433), CT45A5 (ENSG00000228836), CT45A1 (ENSG00000268940), CT45A10 (ENSG00000269586), CT45A9 (ENSG00000270946), CT45A2 (ENSG00000271449), CT45A7 (ENSG00000273696), CT45A8 (ENSG00000278085), CT45A6 (ENSG00000278289)
Protein
Protein identifiers
Cancer/testis antigen family 45 member A3 — Q8NHU0 (reviewed: Q8NHU0)
Alternative names: Cancer/testis antigen 45-3, Cancer/testis antigen 45-4, Cancer/testis antigen 45A3, Cancer/testis antigen 45A4, Cancer/testis antigen family 45 member A4
All UniProt accessions (1): Q8NHU0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Tissue specificity. Testis specific. Expressed in cancer cell lines.
Similarity. Belongs to the CT45 family.
RefSeq proteins (3): NP_001017435, NP_001357077, NP_001357078 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029307 | INT_SG_DDX_CT_C | Domain |
| IPR051113 | Integrator_subunit6 | Family |
Pfam: PF15300
UniProt features (4 total): chain 1, region of interest 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NHU0-F1 | 69.86 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
chrXq26, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL, HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL, RICKMAN_HEAD_AND_NECK_CANCER_B
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
29 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SDCBP2 | CT45A3 | psi-mi:“MI:0915”(physical association) | 0.830 |
| CT45A3 | SDCBP2 | psi-mi:“MI:0915”(physical association) | 0.830 |
| SDCBP | CT45A3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CT45A3 | SDCBP | psi-mi:“MI:0915”(physical association) | 0.720 |
| SF3B1 | SAP18 | psi-mi:“MI:0914”(association) | 0.640 |
| CT45A3 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SUPT5H | POLR2D | psi-mi:“MI:0914”(association) | 0.530 |
| PPP4R2 | TRAPPC13 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS7A | BTBD10 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP4C | ISG15 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP4R2 | KRIT1 | psi-mi:“MI:0914”(association) | 0.350 |
| TP53BP1 | PSMD14 | psi-mi:“MI:2364”(proximity) | 0.270 |
| BRCA1 | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CT45A3 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CT45A3 | SDCBP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CT45A3 | SDCBP | psi-mi:“MI:0915”(physical association) | 0.000 |
| SDCBP | CT45A3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): CT45A3 (Two-hybrid), CT45A3 (Two-hybrid), CT45A3 (Two-hybrid), CT45A3 (Affinity Capture-MS), CT45A3 (Two-hybrid), CT45A3 (Two-hybrid), CT45A3 (Two-hybrid), CT45A3 (Affinity Capture-MS), CT45A3 (Affinity Capture-MS), CT45A3 (Affinity Capture-MS), CT45A3 (Proximity Label-MS)
ESM2 similar proteins: A0FKI7, A2YX04, A5WUN7, A5WV69, A7J1T2, C5DZR8, E9Q555, F4J6F6, O43310, O48767, P0DMS1, P0DMU7, P0DMU8, P0DMU9, P0DMV0, P0DMV1, P0DMV2, Q0V9S3, Q12912, Q14693, Q1LXZ9, Q2NKQ1, Q2PFD7, Q3TEL6, Q502L1, Q5DJT8, Q5R7V3, Q5T8D3, Q5XG73, Q621Z7, Q640U0, Q641E3, Q6IRN6, Q6Z8M8, Q700C2, Q758T8, Q80Y56, Q811D2, Q8AV28, Q8BLN6
Diamond homologs: A6NJ88, P0DMU7, P0DMU8, P0DMU9, P0DMV0, P0DMV1, P0DMV2, Q2TAF4, Q5DJT8, Q5HYN5, Q5JSJ4, Q5U4W6, Q6PCM2, Q7SYD9, Q8BND4, Q8NHU0, Q9NXZ1, Q9UL03, Q54Z23, Q9W485
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
374 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:135764275:GA:G | donor_gain | 1.0000 |
| X:135764269:G:GG | donor_gain | 0.9900 |
| X:135764272:T:G | donor_loss | 0.9900 |
| X:135764273:G:GG | donor_gain | 0.9900 |
| X:135764274:AGTA:A | donor_loss | 0.9900 |
| X:135764275:GAG:G | donor_gain | 0.9900 |
| X:135764276:AGA:A | donor_gain | 0.9900 |
| X:135764277:AAGA:A | donor_gain | 0.9900 |
| X:135764278:AAAGA:A | donor_gain | 0.9900 |
| X:135764449:G:GC | acceptor_loss | 0.9900 |
| X:135764449:G:GG | acceptor_gain | 0.9900 |
| X:135764449:GG:G | acceptor_gain | 0.9900 |
| X:135764449:GGAA:G | acceptor_gain | 0.9900 |
| X:135764449:GGAAA:G | acceptor_gain | 0.9900 |
| X:135764450:A:AG | acceptor_gain | 0.9900 |
| X:135764450:AG:A | acceptor_gain | 0.9900 |
| X:135764450:AGG:A | acceptor_loss | 0.9900 |
| X:135764451:CAG:C | acceptor_loss | 0.9900 |
| X:135764452:TCAGG:T | acceptor_loss | 0.9900 |
| X:135764453:TTCAG:T | acceptor_loss | 0.9900 |
| X:135764454:TTTCA:T | acceptor_loss | 0.9900 |
| X:135764271:A:AG | donor_loss | 0.9800 |
| X:135767890:A:T | donor_gain | 0.9800 |
| X:135764449:GGA:G | acceptor_gain | 0.9700 |
| X:135767937:GACTG:G | donor_gain | 0.9600 |
| X:135767938:GGACT:G | donor_gain | 0.9600 |
| X:135764270:A:AG | donor_gain | 0.9400 |
| X:135765848:A:T | donor_gain | 0.9200 |
| X:135764276:AGAGT:A | donor_gain | 0.9000 |
| X:135767933:G:GG | donor_gain | 0.8900 |
AlphaMissense
1260 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:135761641:C:G | A169P | 0.885 |
| X:135761711:G:C | F145L | 0.858 |
| X:135761711:G:T | F145L | 0.858 |
| X:135761713:A:G | F145L | 0.858 |
| X:135764397:A:C | F16L | 0.848 |
| X:135764397:A:T | F16L | 0.848 |
| X:135764399:A:G | F16L | 0.848 |
| X:135762145:T:A | K127N | 0.837 |
| X:135762145:T:G | K127N | 0.837 |
| X:135761689:C:G | G153R | 0.831 |
| X:135761689:C:T | G153R | 0.831 |
| X:135761660:A:C | F162L | 0.821 |
| X:135761660:A:T | F162L | 0.821 |
| X:135761662:A:G | F162L | 0.821 |
| X:135761663:A:C | F161L | 0.771 |
| X:135761663:A:T | F161L | 0.771 |
| X:135761665:A:G | F161L | 0.771 |
| X:135761703:A:T | L148H | 0.771 |
| X:135762157:A:C | N123K | 0.753 |
| X:135762157:A:T | N123K | 0.753 |
| X:135761664:A:G | F161S | 0.738 |
| X:135762137:A:G | L130S | 0.729 |
| X:135760391:A:C | F177L | 0.726 |
| X:135760391:A:T | F177L | 0.726 |
| X:135760393:A:G | F177L | 0.726 |
| X:135764355:C:A | R30S | 0.722 |
| X:135764355:C:G | R30S | 0.722 |
| X:135760380:A:G | L181P | 0.713 |
| X:135761656:A:G | S164P | 0.713 |
| X:135764373:A:C | S24R | 0.705 |
dbSNP variants (sampled 300 via entrez): RS1157444843 (X:135762865 C>A,T), RS1159567879 (X:135765963 AG>A), RS1159873872 (X:135760305 C>T), RS1161402331 (X:135763043 G>A), RS1162505828 (X:135762884 C>T), RS1164679150 (X:135760791 C>G,T), RS1166764359 (X:135763112 C>T), RS1166993855 (X:135759618 C>G,T), RS1167571698 (X:135765167 G>A), RS1168915208 (X:135760834 G>A), RS1171025699 (X:135759818 G>A), RS1171076552 (X:135759672 TTAATGTGTGTGTAAAA>T), RS1171900195 (X:135765498 A>C), RS1172105453 (X:135761991 T>A), RS1173763686 (X:135762779 A>C)
Disease associations
OMIM: gene MIM:300794 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Cadmium | decreases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Disulfiram | affects binding, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.